Electrocardiogram Signal Analysis With a Machine Learning Model Predicts the Presence of Pulmonary Embolism With Accuracy Dependent on Embolism Burden
- PMID: 40206108
- PMCID: PMC11975982
- DOI: 10.1016/j.mcpdig.2024.03.009
Electrocardiogram Signal Analysis With a Machine Learning Model Predicts the Presence of Pulmonary Embolism With Accuracy Dependent on Embolism Burden
Abstract
Objective: To develop an artificial intelligence deep neural network (AI-DNN) algorithm to analyze 12-lead electrocardiogram (ECG) for detection of acute pulmonary embolism (PE) and PE categories.
Patients and methods: A cohort of patients seen between January 1, 1999, and December 31, 2020, from across the Mayo Clinic Enterprise with computed tomography pulmonary angiogram (CTPA) and ECG performed ±6 hours was identified. Natural language processing algorithms were applied to radiology reports to determine the diagnosis of acute PE, acute right ventricular strain pulmonary embolism (RVSPE), saddle pulmonary embolism (SADPE), or no PE. Diagnostic performance parameters of the AI-DNN reported were area under the receiver operating characteristics curve (AUROC), sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV).
Results: A cohort of patients with CTPA report and ECG consisted of 79,894 patients including 7423 (9.3%) with acute PE, among whom 1138 patients had RVSPE or SADPE. Artificial intelligence deep neural network predicted acute PE with a modest accuracy of AUROC of 0.69 (95% CI, 0.68-0.71), sensitivity of 63.5%, specificity of 64.7%, PPV of 15.6%, and NPV of 94.5%. The AI-DNN prediction using the same algorithm for RVSPE or SADPE was higher (AUROC, 0.84; 95% CI, 0.81-0.86) with a sensitivity of 80.8%, specificity of 64.7.8%, PPV of 3.5%, and NPV of 99.5%.
Conclusion: An AI-based analysis of 12-lead ECG shows modest detection power for acute PE in patients who underwent CTPA, with higher accuracy for high-risk PE. Moreover, with the high NPV, it has the clinical potential to exclude high-risk PE quickly and correctly.
Conflict of interest statement
Given his role as Editor-in-Chief, Dr Francisco Lopez-Jimenez had no involvement in the peer-review of this article and had no access to information regarding its peer-review. Full responsibility for the editorial process for this article was delegated to an unaffiliated Editor. Dr Harmon reports grants from NIH StARR R38 grant (NHLBI): NIH 5R38HL150086-02. Dr Houghton reports grants from Gordan & Betty Moore Foundation, American Society of Hematology, Bayer, Hemostasis & Thrombosis Research Society, Noaber Foundation, Veralox to the institution. The other authors report no competing interests.
Figures
Similar articles
-
How artificial intelligence improves radiological interpretation in suspected pulmonary embolism.Eur Radiol. 2022 Sep;32(9):5831-5842. doi: 10.1007/s00330-022-08645-2. Epub 2022 Mar 22. Eur Radiol. 2022. PMID: 35316363 Free PMC article.
-
Artificial intelligence-based diagnosis of acute pulmonary embolism: Development of a machine learning model using 12-lead electrocardiogram.Rev Port Cardiol. 2023 Jul;42(7):643-651. doi: 10.1016/j.repc.2023.03.016. Epub 2023 Mar 30. Rev Port Cardiol. 2023. PMID: 37001583 English, Portuguese.
-
Single-center outcomes of artificial intelligence in management of pulmonary embolism and pulmonary embolism response team activation.J Investig Med. 2024 Oct;72(7):652-660. doi: 10.1177/10815589241258968. Epub 2024 Jul 31. J Investig Med. 2024. PMID: 39081256
-
Meta-analysis of AI-based pulmonary embolism detection: How reliable are deep learning models?Comput Biol Med. 2025 Jul;193:110402. doi: 10.1016/j.compbiomed.2025.110402. Epub 2025 May 23. Comput Biol Med. 2025. PMID: 40412084 Review.
-
The promise and limitations of artificial intelligence in CTPA-based pulmonary embolism detection.Front Med (Lausanne). 2025 Mar 19;12:1514931. doi: 10.3389/fmed.2025.1514931. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40177281 Free PMC article. Review.
Cited by
-
QTc Prolongation as a Diagnostic Clue in Acute Pulmonary Embolism.J Clin Med. 2025 Jul 15;14(14):5005. doi: 10.3390/jcm14145005. J Clin Med. 2025. PMID: 40725705 Free PMC article.
References
-
- Jaff M.R., McMurtry M.S., Archer S.L., et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011;123(16):1788–1830. doi: 10.1161/CIR.0b013e318214914f. - DOI - PubMed
LinkOut - more resources
Full Text Sources